Literature DB >> 21130223

Meta-analysis of genetic variation in DTNBP1 and general cognitive ability.

Jian-Ping Zhang1, Katherine E Burdick, Todd Lencz, Anil K Malhotra.   

Abstract

BACKGROUND: The human dystrobrevin binding protein 1 (DTNBP1) gene has been linked to risk for schizophrenia. Recent studies indicate that several single nucleotide polymorphisms (SNPs) in the DTNBP1 gene may also influence general cognitive ability in both schizophrenic patients and healthy control subjects. We examined the relationship between DTNBP1 SNPs and general cognitive ability in nonpsychiatric healthy samples via meta-analysis.
METHODS: MEDLINE search (12/31/09) yielded 11 articles examining DTNBP1 variation and general cognitive ability, of which 8 studies had data available encompassing 10 independent cohorts (total n = 7592). The phenotype was defined as either the first principal component score from multiple neuropsychological tests (Spearman's g) or full-scale IQ. Meta-analyses were conducted for nine SNPs for which cognitive data were available from at least three cohorts. For each SNP in each cohort, effect size was computed between major allele homozygotes and minor allele carriers; effect size was then pooled across studies using a random effect model.
RESULTS: Pooled effect sizes from two of the nine SNPs (rs1018381 and rs2619522) were -.123 and -.083, ps < .01, respectively, suggesting that the minor allele carriers of these SNPs had lower cognitive ability scores than the major allele homozygotes. Results remained significant after examining heterogeneity among samples and potential publication biases. Other SNPs did not show significant effects on general cognitive ability.
CONCLUSIONS: Genetic variation in DTNBP1 modestly influences general cognitive ability. Further studies are needed to elucidate the biological mechanisms that may account for this relationship.
Copyright © 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130223      PMCID: PMC3026311          DOI: 10.1016/j.biopsych.2010.09.016

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  47 in total

1.  Genetics and general cognitive ability.

Authors:  R Plomin
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  Meta-analysis of genetic association studies.

Authors:  Marcus R Munafò; Jonathan Flint
Journal:  Trends Genet       Date:  2004-09       Impact factor: 11.639

3.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.

Authors:  Nicole C Allen; Sachin Bagade; Matthew B McQueen; John P A Ioannidis; Fotini K Kavvoura; Muin J Khoury; Rudolph E Tanzi; Lars Bertram
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

4.  Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain.

Authors:  M A Benson; S E Newey; E Martin-Rendon; R Hawkes; D J Blake
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

Review 5.  The hippocampal formation--orbitomedial prefrontal cortex circuit in the attentional control of active memory.

Authors:  P M Wall; C Messier
Journal:  Behav Brain Res       Date:  2001-12-14       Impact factor: 3.332

6.  Variation in the dysbindin gene and normal cognitive function in three independent population samples.

Authors:  M Luciano; F Miyajima; P A Lind; T C Bates; M Horan; S E Harris; M J Wright; W E Ollier; C Hayward; N Pendleton; A J Gow; P M Visscher; J M Starr; I J Deary; N G Martin; A Payton
Journal:  Genes Brain Behav       Date:  2008-12-03       Impact factor: 3.449

7.  Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization.

Authors:  Yukihiko Iizuka; Yoshitatsu Sei; Daniel R Weinberger; Richard E Straub
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

8.  DTNBP1 is associated with imaging phenotypes in schizophrenia.

Authors:  Katherine L Narr; Philip R Szeszko; Todd Lencz; Roger P Woods; Liberty S Hamilton; Owen Phillips; Delbert Robinson; Katherine E Burdick; Pamela DeRosse; Raju Kucherlapati; Paul M Thompson; Arthur W Toga; Anil K Malhotra; Robert M Bilder
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

9.  Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism.

Authors:  Jennifer H Barnett; Linda Scoriels; Marcus R Munafò
Journal:  Biol Psychiatry       Date:  2008-03-14       Impact factor: 13.382

10.  Meta-analysis of genome-wide scans for human adult stature identifies novel Loci and associations with measures of skeletal frame size.

Authors:  Nicole Soranzo; Fernando Rivadeneira; Usha Chinappen-Horsley; Ida Malkina; J Brent Richards; Naomi Hammond; Lisette Stolk; Alexandra Nica; Michael Inouye; Albert Hofman; Jonathan Stephens; Eleanor Wheeler; Pascal Arp; Rhian Gwilliam; P Mila Jhamai; Simon Potter; Amy Chaney; Mohammed J R Ghori; Radhi Ravindrarajah; Sergey Ermakov; Karol Estrada; Huibert A P Pols; Frances M Williams; Wendy L McArdle; Joyce B van Meurs; Ruth J F Loos; Emmanouil T Dermitzakis; Kourosh R Ahmadi; Deborah J Hart; Willem H Ouwehand; Nicholas J Wareham; Inês Barroso; Manjinder S Sandhu; David P Strachan; Gregory Livshits; Timothy D Spector; André G Uitterlinden; Panos Deloukas
Journal:  PLoS Genet       Date:  2009-04-03       Impact factor: 5.917

View more
  16 in total

1.  Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition.

Authors:  Claudia J P Simons; Ruud van Winkel
Journal:  Schizophr Bull       Date:  2012-04-24       Impact factor: 9.306

2.  Genetics of schizophrenia: What do we know?

Authors:  Jian-Ping Zhang; Anil K Malhotra
Journal:  Curr Psychiatr       Date:  2013-03-01

3.  GWAS for executive function and processing speed suggests involvement of the CADM2 gene.

Authors:  D A Bennett; I J Deary; M A Ikram; L J Launer; A L Fitzpatrick; S Seshadri; C M van Duijn; T H Mosley; C A Ibrahim-Verbaas; J Bressler; S Debette; M Schuur; A V Smith; J C Bis; G Davies; S Trompet; J A Smith; C Wolf; L B Chibnik; Y Liu; V Vitart; M Kirin; K Petrovic; O Polasek; L Zgaga; C Fawns-Ritchie; P Hoffmann; J Karjalainen; J Lahti; D J Llewellyn; C O Schmidt; K A Mather; V Chouraki; Q Sun; S M Resnick; L M Rose; C Oldmeadow; M Stewart; B H Smith; V Gudnason; Q Yang; S S Mirza; J W Jukema; P L deJager; T B Harris; D C Liewald; N Amin; L H Coker; O Stegle; O L Lopez; R Schmidt; A Teumer; I Ford; N Karbalai; J T Becker; M K Jonsdottir; R Au; Rsn Fehrmann; S Herms; M Nalls; W Zhao; S T Turner; K Yaffe; K Lohman; J C van Swieten; Slr Kardia; D S Knopman; W M Meeks; G Heiss; E G Holliday; P W Schofield; T Tanaka; D J Stott; J Wang; P Ridker; A J Gow; A Pattie; J M Starr; L J Hocking; N J Armstrong; S McLachlan; J M Shulman; L C Pilling; G Eiriksdottir; R J Scott; N A Kochan; A Palotie; Y-C Hsieh; J G Eriksson; A Penman; R F Gottesman; B A Oostra; L Yu; A L DeStefano; A Beiser; M Garcia; J I Rotter; M M Nöthen; A Hofman; P E Slagboom; Rgj Westendorp; B M Buckley; P A Wolf; A G Uitterlinden; B M Psaty; H J Grabe; S Bandinelli; D I Chasman; F Grodstein; K Räikkönen; J-C Lambert; D J Porteous; J F Price; P S Sachdev; L Ferrucci; J R Attia; I Rudan; C Hayward; A F Wright; J F Wilson; S Cichon; L Franke; H Schmidt; J Ding; Ajm de Craen; M Fornage
Journal:  Mol Psychiatry       Date:  2015-04-14       Impact factor: 15.992

4.  Statistical approaches to harmonize data on cognitive measures in systematic reviews are rarely reported.

Authors:  Lauren E Griffith; Edwin van den Heuvel; Isabel Fortier; Nazmul Sohel; Scott M Hofer; Hélène Payette; Christina Wolfson; Sylvie Belleville; Meghan Kenny; Dany Doiron; Parminder Raina
Journal:  J Clin Epidemiol       Date:  2014-12-08       Impact factor: 6.437

5.  Loss of dysbindin-1 affects GABAergic transmission in the PFC.

Authors:  H Trantham-Davidson; A Lavin
Journal:  Psychopharmacology (Berl)       Date:  2019-06-14       Impact factor: 4.530

6.  Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes.

Authors:  Emilie I Petit; Zuzanna Michalak; Rachel Cox; Colm M P O'Tuathaigh; Niamh Clarke; Orna Tighe; Konrad Talbot; Derek Blake; Josephine Joel; Alexander Shaw; Steven A Sheardown; Alastair D Morrison; Stephen Wilson; Ellen M Shapland; David C Henshall; James N Kew; Brian P Kirby; John L Waddington
Journal:  Neuropsychopharmacology       Date:  2016-12-16       Impact factor: 7.853

7.  Haploinsufficiency of two histone modifier genes on 6p22.3, ATXN1 and JARID2, is associated with intellectual disability.

Authors:  Tuva Barøy; Doriana Misceo; Petter Strømme; Asbjørg Stray-Pedersen; Asbjørn Holmgren; Olaug Kristin Rødningen; Anne Blomhoff; Johan Robert Helle; Alice Stormyr; Bjørn Tvedt; Madeleine Fannemel; Eirik Frengen
Journal:  Orphanet J Rare Dis       Date:  2013-01-07       Impact factor: 4.123

Review 8.  Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade.

Authors:  Cristina A Ghiani; Esteban C Dell'Angelica
Journal:  ASN Neuro       Date:  2011-05-27       Impact factor: 4.146

9.  Beyond the GWAS in schizophrenia.

Authors:  Anil K Malhotra
Journal:  EMBO Mol Med       Date:  2011-05-03       Impact factor: 12.137

10.  Loss of dysbindin-1, a risk gene for schizophrenia, leads to impaired group 1 metabotropic glutamate receptor function in mice.

Authors:  Sanjeev K Bhardwaj; Richard T Ryan; Tak Pan Wong; Lalit K Srivastava
Journal:  Front Behav Neurosci       Date:  2015-03-26       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.